Chris Robillard

Corporate Officer/Principal presso CRINETICS PHARMACEUTICALS, INC.

Health Technology

Consumer Services

Posizioni attive di Chris Robillard

Società	Posizione	Inizio	Fine
CRINETICS PHARMACEUTICALS, INC.	Corporate Officer/Principal	21/03/2022	-

Società	Posizione	Inizio	Fine
KARYOPHARM THERAPEUTICS INC.	Corporate Officer/Principal	-	-
Goldfinch Bio, Inc. Goldfinch Bio, Inc. Pharmaceuticals: MajorHealth Technology Goldfinch Bio, Inc. operates as a biotechnology company. It focuses on discovering and developing precision therapies for patients with kidney disease. The firm develops and manufactures medicines. The company was founded by Joseph Vincent Bonventre, Anna Greka, Fridhelm Hildebrandt, Daniel MacArthur, Stefan Somlo and Peter Mundel in December 2016 and is headquartered in Cambridge, MA.	Corporate Officer/Principal	-	-

Lehigh University	Undergraduate Degree
Pepperdine University	Masters Business Admin

Distribuzione geografica

Stati Uniti

Posizioni

Corporate Officer/Principal	3
Undergraduate Degree	1
Masters Business Admin	1

Settori

Health Technology	4
Consumer Services	3

Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Società quotate in Borsa	2
CRINETICS PHARMACEUTICALS, INC.	Health Technology
KARYOPHARM THERAPEUTICS INC.	Health Technology

Aziende private	1
Goldfinch Bio, Inc. Goldfinch Bio, Inc. Pharmaceuticals: MajorHealth Technology Goldfinch Bio, Inc. operates as a biotechnology company. It focuses on discovering and developing precision therapies for patients with kidney disease. The firm develops and manufactures medicines. The company was founded by Joseph Vincent Bonventre, Anna Greka, Fridhelm Hildebrandt, Daniel MacArthur, Stefan Somlo and Peter Mundel in December 2016 and is headquartered in Cambridge, MA.	Health Technology

Aziende private

Health Technology